SCIEQ1
Cancer Biology & Medicine
CHINA ANTI-CANCER ASSOC
Cancer Biology & Medicine is an academic journal published by CHINA ANTI-CANCER ASSOC. Identifiers: ISSN 2095-3941, eISSN 2095-3941. Indexed in SCIE. Metrics: JIF 8.4. Subject areas: MEDICINE, ONCOLOGY, RESEARCH & EXPERIMENTAL. tlooto lists 1,283 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2095-3941
- eISSN
- 2095-3941
- Abbreviation
- CANCER BIOL MED
- Publisher
- CHINA ANTI-CANCER ASSOC
- Country
- -
Web of Science categories
SCIEMEDICINE, ONCOLOGY, RESEARCH & EXPERIMENTAL
Scopus ASJC categories
No ASJC category data available.
Keywords
Oncology | Medicine, Research & Experimental
Papers in this journal
Recent papers
- A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer.
2026
- Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities.
2026
- Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy
2026 · 1 citations
- HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.
2026
- First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients
2026 · 1 citations
Most cited papers
- Epidemiology of ovarian cancer: a review
2017 · 1,378 citations
- Current approaches in treatment of triple-negative breast cancer
2015 · 483 citations
- HOTAIR: an oncogenic long non-coding RNA in different cancers
2015 · 448 citations
- Incidence and mortality of female breast cancer in the Asia-Pacific region
2014 · 427 citations
- Biological and clinical aspects of HPV-related cancers
2020 · 320 citations